PHAC_HALMT
ID PHAC_HALMT Reviewed; 492 AA.
AC I3R9Z4; B3FRM5;
DT 14-MAY-2014, integrated into UniProtKB/Swiss-Prot.
DT 05-SEP-2012, sequence version 1.
DT 03-AUG-2022, entry version 50.
DE RecName: Full=Poly(3-hydroxyalkanoate) polymerase subunit PhaC;
DE Short=PHA polymerase;
DE EC=2.3.1.-;
DE AltName: Full=PHB synthase subunit PhaC;
DE AltName: Full=Poly(3-hydroxybutyrate) polymerase subunit PhaC;
DE Short=PHB polymerase;
DE AltName: Full=Polyhydroxyalkanoic acid synthase subunit PhaC;
DE Short=PHA synthase;
GN Name=phaC; OrderedLocusNames=HFX_5221; ORFNames=C439_00140;
OS Haloferax mediterranei (strain ATCC 33500 / DSM 1411 / JCM 8866 / NBRC
OS 14739 / NCIMB 2177 / R-4) (Halobacterium mediterranei).
OG Plasmid pHM300.
OC Archaea; Euryarchaeota; Stenosarchaea group; Halobacteria; Haloferacales;
OC Haloferacaceae; Haloferax.
OX NCBI_TaxID=523841;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND DISRUPTION PHENOTYPE.
RC STRAIN=ATCC 33500 / DSM 1411 / JCM 8866 / NBRC 14739 / NCIMB 2177 / R-4;
RC PLASMID=pHM300;
RX PubMed=18408025; DOI=10.1128/jb.00134-08;
RA Lu Q., Han J., Zhou L., Zhou J., Xiang H.;
RT "Genetic and biochemical characterization of the poly(3-hydroxybutyrate-co-
RT 3-hydroxyvalerate) synthase in Haloferax mediterranei.";
RL J. Bacteriol. 190:4173-4180(2008).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC 33500 / DSM 1411 / JCM 8866 / NBRC 14739 / NCIMB 2177 / R-4;
RC PLASMID=pHM300;
RX PubMed=22843593; DOI=10.1128/jb.00880-12;
RA Han J., Zhang F., Hou J., Liu X., Li M., Liu H., Cai L., Zhang B., Chen Y.,
RA Zhou J., Hu S., Xiang H.;
RT "Complete genome sequence of the metabolically versatile halophilic
RT archaeon Haloferax mediterranei, a poly(3-hydroxybutyrate-co-3-
RT hydroxyvalerate) producer.";
RL J. Bacteriol. 194:4463-4464(2012).
RN [3]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC 33500 / DSM 1411 / JCM 8866 / NBRC 14739 / NCIMB 2177 / R-4;
RC PLASMID=pHM300;
RX PubMed=25393412; DOI=10.1371/journal.pgen.1004784;
RA Becker E.A., Seitzer P.M., Tritt A., Larsen D., Krusor M., Yao A.I., Wu D.,
RA Madern D., Eisen J.A., Darling A.E., Facciotti M.T.;
RT "Phylogenetically driven sequencing of extremely halophilic archaea reveals
RT strategies for static and dynamic osmo-response.";
RL PLoS Genet. 10:E1004784-E1004784(2014).
CC -!- FUNCTION: Involved in the production of polyhydroxyalkonic acids
CC (PHAs), which are water-insoluble biopolymers used as intracellular
CC energy reserve material when cells grow under conditions of nutrient
CC limitation. PHAs are composed primarily of 3-hydroxybutyric acid (3HB)
CC and 3-hydroxyvaleric acid (3HV). Required for the production of poly-
CC beta-hydroxybutyrate (PHB) and poly(beta-hydroxybutyrate-co-beta-
CC hydroxyvalerate) (PHBV). {ECO:0000269|PubMed:18408025}.
CC -!- PATHWAY: Biopolymer metabolism; poly-(R)-3-hydroxybutanoate
CC biosynthesis.
CC -!- SUBUNIT: Heterodimer with PhaE. {ECO:0000250}.
CC -!- DISRUPTION PHENOTYPE: Depletion of both phaC and phaE genes leads to
CC complete loss of PHA synthase activity and PHBV production.
CC {ECO:0000269|PubMed:18408025}.
CC -!- BIOTECHNOLOGY: PHB and PHBV are desirable bioplastic due to their
CC biodegradability, biocompatibility, and mechanical properties. However,
CC PHBV has better mechanical properties than PHB.
CC -!- SIMILARITY: Belongs to the PHA/PHB synthase family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; EU374220; ACB10370.1; -; Genomic_DNA.
DR EMBL; CP001870; AFK21054.1; -; Genomic_DNA.
DR EMBL; AOLO01000001; EMA05161.1; -; Genomic_DNA.
DR RefSeq; WP_004056138.1; NZ_CP039141.1.
DR AlphaFoldDB; I3R9Z4; -.
DR SMR; I3R9Z4; -.
DR ESTHER; halme-b3frm5; PHA_synth_III_C.
DR EnsemblBacteria; AFK21054; AFK21054; HFX_5221.
DR EnsemblBacteria; EMA05161; EMA05161; C439_00140.
DR GeneID; 40158350; -.
DR KEGG; hme:HFX_5221; -.
DR HOGENOM; CLU_035017_2_0_2; -.
DR OMA; YLIDWGY; -.
DR OrthoDB; 22660at2157; -.
DR BRENDA; 2.3.1.304; 2566.
DR UniPathway; UPA00917; -.
DR Proteomes; UP000006469; Plasmid pHM300.
DR Proteomes; UP000011603; Unassembled WGS sequence.
DR GO; GO:0016746; F:acyltransferase activity; IEA:UniProtKB-KW.
DR GO; GO:0000166; F:nucleotide binding; IEA:InterPro.
DR GO; GO:0042621; P:poly(3-hydroxyalkanoate) biosynthetic process; IEA:UniProtKB-KW.
DR GO; GO:0042619; P:poly-hydroxybutyrate biosynthetic process; IEA:UniProtKB-KW.
DR Gene3D; 3.40.50.1820; -; 1.
DR InterPro; IPR029058; AB_hydrolase.
DR InterPro; IPR000073; AB_hydrolase_1.
DR InterPro; IPR010995; DNA_repair_Rad51/TF_NusA_a-hlx.
DR InterPro; IPR010125; PHA_synth_III_C.
DR Pfam; PF00561; Abhydrolase_1; 1.
DR SUPFAM; SSF47794; SSF47794; 1.
DR SUPFAM; SSF53474; SSF53474; 1.
DR TIGRFAMs; TIGR01836; PHA_synth_III_C; 1.
PE 1: Evidence at protein level;
KW Acyltransferase; PHA biosynthesis; PHB biosynthesis; Plasmid; Transferase.
FT CHAIN 1..492
FT /note="Poly(3-hydroxyalkanoate) polymerase subunit PhaC"
FT /id="PRO_0000428871"
FT DOMAIN 70..336
FT /note="AB hydrolase-1"
FT /evidence="ECO:0000255"
FT REGION 359..443
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 359..376
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 411..425
FT /note="Acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT ACT_SITE 150
FT /note="Charge relay system"
FT /evidence="ECO:0000255"
FT ACT_SITE 305
FT /note="Charge relay system"
FT /evidence="ECO:0000255"
FT ACT_SITE 334
FT /note="Charge relay system"
FT /evidence="ECO:0000255"
SQ SEQUENCE 492 AA; 54765 MW; AB5EB91BA93D49C6 CRC64;
MTPVTFALDL QRRQWEQAAE LVDRTSAASD RAETVSEVSV GKTPNEVVYK ENKLRLLHYE
SKTETQYDVP ILIVYALINR PYILDLQPDR SVVQTLLEQG FDVYLIDWGE PSRLDTHLTL
DDYVTRYIDN CVDIVRDRSG QDSINLLGYC MGGTMSVMYA ALFPEKVRNL GLMAAGLVFD
DTGGVLERWG DEQYYSPKAV TDAFGNVPSE FLDVGFALMD PVENFVTKYV RLFENVENES
FVENFSRMEQ WLSDGIDVAG ETYKQFLEDV YQQNKLAQNE LMLDGKQVDL ERLEMPILQI
VGEYDHLIPP EASKPFNDLV PSEDTEVIEG ATGHIGLSVS SRSHGDLWPA VSDWFAERSE
TGTDETPDSE TEETRPDSQA EETDETPDEG LKPQAAASNE TVAEEPEPQV VESNETTEEE
LEPQAVEANE TAPEELESID GIGPTYAERL ASVGITSVSG LAAADPSEIA ATIDVPVSRV
TAWVEQASDR TD